Greg Behar

Greg Behar is an experienced executive currently serving as Chief Executive Officer at Recipharm since January 2024. Additionally, Behar holds board member positions at Bespak, NewBiologix, Sonova Group, and Amazentis. Previously, Behar was President & CEO at Nestlé Health Science from July 2014 to December 2023 and served on various boards, including Seres Therapeutics, Axcella, Aimmune Therapeutics, and Cerecin. Educational qualifications include an MBA from Harvard Business School, an MBA from INSEAD, and an Engineer's Degree in Manufacturing Engineering from EPFL, along with undergraduate studies at UCLA.